Effects of a Wholegrain Diet on Body Composition and Energy Balance
Effects of Diet on Body Composition
1 other identifier
interventional
35
1 country
1
Brief Summary
The purpose of this study is to compare a diet containing whole grains versus an energy matched diet using refined grains on body composition and metabolism.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2010
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2010
CompletedFirst Submitted
Initial submission to the registry
July 27, 2011
CompletedFirst Posted
Study publicly available on registry
August 8, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedJanuary 10, 2017
January 1, 2017
4.5 years
July 27, 2011
January 6, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in body composition
The primary outcome is the change in body composition after an eight-week intervention of either whole grains or refined grains, corrected for baseline body composition at the start of the appropriate treatment arm.
24 months
Secondary Outcomes (3)
Total energy expenditure
Eight-week cross-over trial with 10 week washout period between intervention arms.
Glucose turnover
Eight weeks
Protein turnover
Eight weeks
Study Arms (2)
Whole grain diet
EXPERIMENTALSubjects will eat a whole grain based diet for eight weeks. Pre-and post-diet intervention testing will determine effects on body composition. Whole grain-based are will be compared to the refined grain based diet.
Refined grain diet
ACTIVE COMPARATORSubjects will eat a refined grain diet for 8 weeks matched with the whole grain arm for calorie and macro nutrient intake. Pre-and post-diet testing will determine effects on body composition.
Interventions
Comparison of a diet containing whole grain compared to an energy matched diet based on similar foods, but using refined grains.
Eligibility Criteria
You may qualify if:
- Aged between 20-50 years
- BMI between 25 and 38 kg/m2
- Normal whole grain intake \<1 serving/d (Appendix 1)
- Low average consumption of alcohol (\<1 standard drink/day; \<7 standard drinks/week)
- Non-smoker
- No major chronic illness
- Fasting glucose \<126 mg/dl
- Able to access the study centre (Lerner Research Institute and the Clinical Research Unit at the Cleveland Clinic) throughout the study
- Have access to a microwave oven and refrigerator/freezer
You may not qualify if:
- Any known food allergy with the possibility to result in a serious adverse reaction, or an allergy to a food item that cannot be removed from the diet (i.e. peanuts).
- Aversion or dislike to study foods
- Regular use of dietary supplements and not willing/able to stop usage during the study period
- Cardiovascular conditions including significant known coronary artery disease, arrhythmia, known peripheral vascular disease (large vessel disease), uncompensated congestive heart failure, history of stroke, or uncontrolled hypertension (defined as medically treated with the mean of 3 separate measurements SBP \> 180 mm Hg or DBP \> 110 mm Hg)
- Severe pulmonary disease defined as FEV1 \< 50% of predicted value
- Kidney disease including diagnosed chronic kidney disease, renovascular hypertension, renal artery stenosis, or chronic renal insufficiency with a creatinine level \> 1.8 mg/dl
- Known history of chronic liver disease (except for NAFLD), hepatitis, positive serologic test result for hepatitis B surface antigen and/or hepatitis C antibody, α-1-antitrypsin deficiency
- GI disorders including a known history of celiac disease and/or any other malabsorptive disorders or inflammatory bowel disease (Crohn's disease or ulcerative colitis)
- Psychiatric disorders including dementia, active psychosis, severe depression (requiring \> 2 medications), history of suicide attempts, alcohol or drug abuse within the previous 12 months
- Other known metabolic disease such as clinical hypothyroidism and hyper thyroidism, Graves Disease, thyroid cancer, nodules or multinodular goiter
- Malignancy within five years (except squamous cell and basal cell cancer of the skin)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Cleveland Cliniclead
- Société des Produits Nestlé (SPN)collaborator
Study Sites (1)
Cleveland Clinic
Cleveland, Ohio, 44195, United States
Related Publications (3)
Mey JT, Godin JP, Scelsi AR, Kullman EL, Malin SK, Yang S, Floyd ZE, Poulev A, Fielding RA, Ross AB, Kirwan JP. A Whole-Grain Diet Increases Whole-Body Protein Balance Compared with a Macronutrient-Matched Refined-Grain Diet. Curr Dev Nutr. 2021 Sep 25;5(11):nzab121. doi: 10.1093/cdn/nzab121. eCollection 2021 Nov.
PMID: 34805723DERIVEDMalin SK, Kullman EL, Scelsi AR, Haus JM, Filion J, Pagadala MR, Godin JP, Kochhar S, Ross AB, Kirwan JP. A whole-grain diet reduces peripheral insulin resistance and improves glucose kinetics in obese adults: A randomized-controlled trial. Metabolism. 2018 May;82:111-117. doi: 10.1016/j.metabol.2017.12.011. Epub 2018 Jan 3.
PMID: 29305946DERIVEDKirwan JP, Malin SK, Scelsi AR, Kullman EL, Navaneethan SD, Pagadala MR, Haus JM, Filion J, Godin JP, Kochhar S, Ross AB. A Whole-Grain Diet Reduces Cardiovascular Risk Factors in Overweight and Obese Adults: A Randomized Controlled Trial. J Nutr. 2016 Nov;146(11):2244-2251. doi: 10.3945/jn.116.230508. Epub 2016 Oct 19.
PMID: 27798329DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John P. Kirwan, Ph.D.
The Cleveland Clinic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Staff, Department of Pathobiology
Study Record Dates
First Submitted
July 27, 2011
First Posted
August 8, 2011
Study Start
June 1, 2010
Primary Completion
December 1, 2014
Study Completion
December 1, 2014
Last Updated
January 10, 2017
Record last verified: 2017-01